Evaluation Interest of the Circulating Tumor DNA Dosage in Patient With Hepatic Metastatic Uveal Melanoma Candidate to Complete Resection (ct DNA R0)

Inclusion Criteria

• •1. Aged 18 years old or more
• •2. Patient with hepatic injury of metastatic uveal melanoma eligible for curative surgery (R0).
• •3. No other distant metastasis (CT thoracic -abdomino -pelvic, bone scan).Measurable metastatic disease (echography, CT and/or MRI, FDG-PET, (fluoro- D-glucose integrated with computed tomography)).
• •4. Patient able to stand a blood collection.
• •5. Patient explanation given and consent information signed or by legal representative.